Biochem and BASF Announce Agreement for Biochem’s Acquisition of BASF's Global Glycinate Business
Lohne and Ludwigshafen, Germany, November 25th, 2025 – Biochem, an innovative animal nutrition company specializing in feed additives and dietary supplements, and BASF have entered into a binding agreement on Biochem’s acquisition of BASF's global glycinate business.
This strategic acquisition reinforces Biochem's role as a pioneer in high-performance organic trace minerals (OTMs) since 1992 and broadens its global market presence. By acquiring this business, Biochem gains enhanced market access and a well-established network of distribution partners from BASF, guaranteeing a seamless transition for all customers worldwide.
Following BASF’s recent announcement to explore strategic options for its feed enzyme business, for BASF, this divestiture represents another step in refining the portfolio toward core ingredients for human and animal nutrition. While the review of strategic options for the feed enzyme business is still underway, the company remains fully committed to supporting customers and advancing the business—driving growth and innovation throughout this transition.
The glycinate portfolios of both companies share a strong, science-backed value proposition, focused on delivering superior results for animal producers, namely:
Improved Animal Performance: The high bioavailability of glycinates ensures better mineral absorption, which directly supports animal health, immunity, and growth.
Environmental Sustainability: Using highly efficient minerals reduces the excretion of key trace elements like zinc and copper into the environment, helping producers meet increasingly strict regulations.
Feed Formulation Stability: The chemically stable structure of glycinates prevents negative interactions with sensitive feed ingredients like vitamins and enzymes, preserving overall diet quality.
"This acquisition is a pivotal moment for Biochem, but more importantly, for feed and animal protein producers around the world," said Dr. Alexander Grafe, CEO of Biochem. "By integrating BASF's glycinate business, we are bringing our sustainable and science-driven portfolio to an even larger global audience, empowering farmers to produce food more efficiently and sustainably."
Expressing confidence in the transition, Uta Dirring, Head of Global Product Management & Marketing Feed Enzymes & Feed PIs at BASF, said, "We take great pride in the high-quality glycinate business we have built, founded on scientific innovation and strong partnerships. Biochem's long-standing expertise and pioneer status in organic trace minerals make them the ideal new home for this business. We are confident that our glycinates, and most importantly our valued partners and customers, will be in excellent hands."
Biochem, a longtime pioneer in organic trace minerals, will integrate BASF's products into its portfolio. For decades, Biochem has been at the forefront with its premium EcoTrace® and B.I.O.Key® lines, with EcoTrace® first launching in 2007. The company’s deep experience in this market is backed by extensive scientific documentation. This commitment is further demonstrated by BetaTrace®, a new, patent-pending OTM innovation that brings together the added value of betaine with an improved trace mineral bioavailability. To ensure smooth transition and continuous product availability, Biochem will continue to partner with BASF's trusted distributors, highlighting its commitment to customer service and supply chain reliability.
Business continuity for customers will be ensured throughout the transition process. Both parties agreed not to disclose financial details of the transaction which is expected to close during the first quarter of 2026.
